NTRA logo

Natera (NTRA)

Profile

Full Name

Natera, Inc.

Ticker Symbol

NTRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

July 1, 2015

Indexes

Not included

Website

http://www.natera.com

Employees

4424

Key Details

Price

$148.56(+2.72%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.70B(+56.75% YoY)

Annual EPS

-$1.53(+59.52% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$148.56
NTRA price is $148.56

30-Day Relative Volume

0.53
NTRA 30-day relative volume is 0.53

Price Performance

Price Most recent change

+2.72%
NTRA price was up +2.72% on Apr 23, 2025

Price YTD change

-6.15%
NTRA price is down -6.15% since January 1st

Price 1-year change

+63.18%
NTRA price is up +63.18% year-on-year

Price 3-year change

+309.37%
NTRA price is up +309.37% over the past 3 years

Price Range

Price All-time high

$183.00
NTRA price is currently -18.82% below its historical high of $183.00

Price 3-year low

$27.35
NTRA price is currently +443.18% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$20.08B
NTRA market capitalization is $20.08 billion

Market cap 3-year change

+475%
NTRA market capitalization is up +475% over the past 3 years

Market cap All-time high

$23.87B
NTRA market capitalization is currently -15.88% below its historical high of $23.87 billion

Market cap sector rank

95.61%
NTRA market capitalization is higher than 95.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+10.59%
NTRA shares outstanding is up +10.59% year-on-year

Shares Outstanding 3-Year Change

+40.46%
NTRA shares outstanding is up +40.46% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.37
NTRA beta is 1.37

200-day SMA

$140.88
NTRA price is currently +5.45% above its 200-day simple moving average

50-day SMA

$150.24
NTRA price is currently -1.12% below its 50-day simple moving average

RSI

51.63
NTRA 14-day relative strength index is 51.63

Volume

0.53
NTRA 30-day relative volume is 0.53

ATR

$7.19
NTRA average true range is $7.19

10-day Historical Volatility

89.08%
NTRA 10-day historical volatility is 89.08%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.70B
NTRA annual revenue is $1.70 billion

Revenue Analysts estimate

$1.92B
NTRA annual revenue is currently -11.65% lower than the consensus analysts' forecast

Revenue 1-year change

+56.75%
NTRA annual revenue is up +56.75% year-on-year

Revenue Sector rank

83.56%
NTRA annual revenue is higher than 83.56% of companies in Healthcare sector

EPS

EPS

-$1.53
NTRA annual earnings per share is -$1.53

EPS Analysts estimate

-$2.22
NTRA annual earnings per share is currently -31.11% lower than the consensus analysts' forecast

EPS 1-year change

+59.52%
NTRA annual earnings per share is up +59.52% year-on-year

EPS Sector rank

45%
NTRA annual earnings per share is higher than 45% of companies in Healthcare sector

Profit

Gross profit

$1.02B
NTRA annual gross profit is $1.02 billion

Gross margin

60.30%
NTRA annual gross profit margin is 60.30%

Operating profit

-$222.29M
NTRA annual operating income is -$222.29 million

Operating margin

-13.10%
NTRA annual operating profit margin is -13.10%

Net income

-$190.43M
NTRA annual net profit is -$190.43 million

Net margin

-11.22%
NTRA annual net profit margin is -11.22%

Expenses

Total expenses

$1.92B
NTRA annual total expenses is $1.92 billion

Operating expenses

$1.25B
NTRA annual total operating expenses is $1.25 billion

Cost of goods sold

$673.75M
NTRA annual cost of goods sold is $673.75 million

Selling, general & administrative expenses

$841.31M
NTRA annual SGA is $841.31 million

Depreciation and amortization

$30.97M
NTRA annual depreciation & amortization is $30.97 million

Interest expense

$10.69M
NTRA annual interest expense is $10.69 million

Income tax

$695.00K
NTRA annual income tax is $695.00 thousand

EBIT & EBITDA

EBIT

-$179.05M
NTRA annual earnings before interest & taxes is -$179.05 million

EBITDA

-$148.08M
NTRA annual EBITDA is -$148.08 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.66B
NTRA annual total assets is $1.66 billion

Non current assets

$284.92M
NTRA annual long term assets is $284.92 million

Current assets

$1.38B
NTRA annual total current assets is $1.38 billion

Cash and cash equivalents

$945.59M
NTRA annual cash & cash equivalents is $945.59 million

Accounts receivable

$314.17M
NTRA annual accounts receivable is $314.17 million

Inventory

$44.74M
NTRA annual inventory is $44.74 million

Liabilities

Total liabilities

$465.31M
NTRA annual total liabilities is $465.31 million

Long term liabilities

$121.27M
NTRA annual total long term liabilities is $121.27 million

Current liabilities

$344.05M
NTRA annual total current liabilities is $344.05 million

Accounts payable

$34.92M
NTRA annual accounts payable is $34.92 million

Debt

Total debt

$187.12M
NTRA annual total debt is $187.12 million

Total debt 1-year change

-57.66%
NTRA annual total debt is down -57.66% year-on-year

Long term debt

$96.59M
NTRA annual long term debt is $96.59 million

Short term debt

$90.53M
NTRA annual short term debt is $90.53 million

Equity & Capital

Shareholders equity

$1.20B
NTRA annual stockholders equity is $1.20 billion

Book value

$1.20B
NTRA annual book value is $1.20 billion

Retained earnings

-$2.57B
NTRA annual retained earnings is -$2.57 billion

Working capital

$1.03B
NTRA annual working capital is $1.03 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$135.66M
NTRA annual cash flow from operations is $135.66 million

Cash from operations 1-year change

+154.93%
NTRA annual cash flow from operations is up +154.93% year-on-year

Cash from investing

$137.62M
NTRA annual cash flow from investing activities is $137.62 million

Cash from investing 1-year change

-18.32%
NTRA annual cash flow from investing activities is down -18.32% year-on-year

Cash from financing

$30.20M
NTRA annual cash flow from financing activities is $30.20 million

Cash from financing 1-year change

-88.13%
NTRA annual cash flow from financing activities is down -88.13% year-on-year

CAPEX

CAPEX

$76.92M
NTRA annual capital expenditures is $76.92 million

CAPEX 1-year change

+96.22%
NTRA annual capital expenditures is up +96.22% year-on-year

Free Cash Flow

Free cash flow

$58.75M
NTRA annual free cash flow is $58.75 million

Free cash flow 1-year change

+120.53%
NTRA annual free cash flow is up +120.53% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

60.30%
NTRA annual gross profit margin is 60.30%

Operating margin

-13.10%
NTRA annual operating profit margin is -13.10%

Net margin

-11.22%
NTRA annual net profit margin is -11.22%

ROA & ROE

ROA

-12.28%
NTRA annual return on assets is -12.28%

ROE

-19.42%
NTRA annual return on equity is -19.42%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NTRA price to earnings ratio value is unknown

PE ratio Sector rank

-
NTRA price to earnings ratio is unknown

PB Ratio

PB ratio

16.80
NTRA price to book ratio is 16.80

PB ratio Sector rank

95.85%
NTRA price to book ratio is higher than 95.85% of companies in Healthcare sector

PS Ratio

PS ratio

11.84
NTRA price to sales ratio is 11.84

PS ratio Sector rank

80.42%
NTRA price to sales ratio is higher than 80.42% of companies in Healthcare sector

Enterprise value

Enterprise value

$19.32B
NTRA enterprise value is $19.32 billion

Enterprise value Sector rank

94.75%
NTRA enterprise value is higher than 94.75% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-130.50
NTRA EV/EBITDA is -130.50

EV/EBITDA Sector rank

0.88%
NTRA EV/EBITDA is higher than 0.88% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.00
NTRA annual current ratio is 4.00

Quick ratio

3.87
NTRA annual quick ratio is 3.87

Leverage

Debt to equity

0.07
NTRA annual debt to equity ratio is 0.07

Interest coverage ratio

-16.76
NTRA annual interest coverage ratio is -16.76

Risk & Stability

Piotroski F-Score

5
NTRA piotroski f-score is 5

Altman Z-Score

25.14
NTRA altman z-score is 25.14

Analyst ratings

Recent major analysts updates

Apr 10, 25 Barclays
Overweight
Mar 13, 25 RBC Capital
Outperform
Mar 5, 25 Morgan Stanley
Overweight
Mar 4, 25 Piper Sandler
Overweight
Feb 28, 25 Canaccord Genuity
Buy
Feb 28, 25 Baird
Outperform
Feb 26, 25 Canaccord Genuity
Buy
Jan 28, 25 Goldman Sachs
Buy
Jan 23, 25 Barclays
Overweight
Jan 17, 25 Guggenheim
Buy

Institutional Ownership

Similar stocks

WAT logo
Waters (WAT)
ZBH logo
Zimmer Biomet Holdings (ZBH)
DGX logo
Quest Diagnostics Incorporated (DGX)
LH logo
Laboratory Corporation of America Holdings (LH)
MOH logo
Molina Healthcare (MOH)
MTD logo
Mettler-Toledo International (MTD)
STE logo
STERIS (STE)
PHG logo
Koninklijke Philips NV (PHG)
PODD logo
Insulet (PODD)
  • What is the ticker symbol for Natera?
  • Does Natera pay dividends?
  • What sector is Natera in?
  • What industry is Natera in?
  • What country is Natera based in?
  • When did Natera go public?
  • Is Natera in the S&P 500?
  • Is Natera in the NASDAQ 100?
  • Is Natera in the Dow Jones?
  • When was Natera's last earnings report?
  • When does Natera report earnings?
  • Should I buy Natera stock now?

What is the ticker symbol for Natera?

The ticker symbol for Natera is NASDAQ:NTRA

Does Natera pay dividends?

No, Natera does not pay dividends

What sector is Natera in?

Natera is in the Healthcare sector

What industry is Natera in?

Natera is in the Diagnostics & Research industry

What country is Natera based in?

Natera is headquartered in United States

When did Natera go public?

Natera's initial public offering (IPO) was on July 1, 2015

Is Natera in the S&P 500?

No, Natera is not included in the S&P 500 index

Is Natera in the NASDAQ 100?

No, Natera is not included in the NASDAQ 100 index

Is Natera in the Dow Jones?

No, Natera is not included in the Dow Jones index

When was Natera's last earnings report?

Natera's most recent earnings report was on Feb 27, 2025

When does Natera report earnings?

The next expected earnings date for Natera is May 9, 2025

Should I buy Natera stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page